Germline genetic variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA are associated with pathologic complete response to bevacizumab in breast cancer patients
Issam Makhoul, Valentina K. Todorova, Eric R. Siegel, Stephen W. Erickson, Ishwori Dhakal, Vinay R. Raj, Jeannette Y. Lee, Mohammed S. Orloff, Robert J. Griffin, Ronda S. Henry-Tillman, Suzanne Klimberg, Laura F. Hutchins, Susan A. Kadlubar
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Germline genetic variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA are associated with pathologic complete response to bevacizumab in breast cancer patients'. Together they form a unique fingerprint.